Cargando…
Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation
The success of antipsychotic drug treatment in patients with schizophrenia is limited by the propensity of these drugs to induce hyperphagia, weight gain and other metabolic disturbances, particularly evident for olanzapine and clozapine. However, the molecular mechanisms involved in antipsychotic-i...
Autores principales: | Fernø, Johan, Varela, Luis, Skrede, Silje, Vázquez, María Jesús, Nogueiras, Rubén, Diéguez, Carlos, Vidal-Puig, Antonio, Steen, Vidar M., López, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113797/ https://www.ncbi.nlm.nih.gov/pubmed/21695181 http://dx.doi.org/10.1371/journal.pone.0020571 |
Ejemplares similares
-
Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat
por: Jassim, Goran, et al.
Publicado: (2011) -
Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats
por: Skrede, Silje, et al.
Publicado: (2017) -
Hypothalamic mTOR Signaling Mediates the Orexigenic Action of Ghrelin
por: Martins, Luís, et al.
Publicado: (2012) -
Activity-Based Anorexia Induces Browning of Adipose Tissue Independent of Hypothalamic AMPK
por: Fraga, Angela, et al.
Publicado: (2021) -
Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex
por: Ersland, Kari M., et al.
Publicado: (2017)